Der var små, men ikke klinisk signifikante stigninger i LDL- kolesterolniveauer.
In most clinical trials, reduced total plasma triglycerides and free fatty acids, and increased HDL-cholesterol levels were observed as compared to placebo, with small, but not clinically significant increases in LDL-cholesterol levels.